PMID: 11917808Mar 29, 2002Paper

The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century

Infectious Disease Clinics of North America
J Peter CegielskiM C Raviglione

Abstract

Mycobacterium tuberculosis has been identified in prehistoric remains of humans. Despite references to TB by Hippocrates and Galen, humankind had limited understanding of and few tools to defend itself against TB until the later 19th century. Subsequently, landmark advances in the 20th century provided the means to control and prevent this disease. At the same time, epidemiological developments and fundamental problems related to human behavior, socioeconomic conditions, and political circumstances continue to thwart efforts to diminish the burden of suffering and death caused by TB. This article reviewed some of these issues including the global failure of TB control in the late 20th century, the worldwide emergence of drug-resistant TB, the extensive spread of HIV infection and its impact on TB incidence; and changing health care and political environments. The obstacles to TB control remain and will remain challenges in the coming years. Still, recent developments in immunology, biochemistry, and molecular biology suggest that new knowledge and tools are just around the corner. These will enhance the ability to conquer this microbe by the end of the current century.

References

Sep 9, 1992·JAMA : the Journal of the American Medical Association·C Beck-SaguéW R Jarvis
Sep 23, 1992·JAMA : the Journal of the American Medical Association·K M De CockS B Lucas
Jul 22, 1992·JAMA : the Journal of the American Medical Association·P A SelwynE E Schoenbaum
Jan 1, 1991·AIDS·B G WenigerC Wasi
Jan 31, 1991·The New England Journal of Medicine·P M SmallP C Hopewell
Oct 1, 1991·American Journal of Public Health·R LongE Hershfield
Nov 21, 1986·Science·T C QuinnP Piot
Jul 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·P Godfrey-FaussettK McAdam
Aug 1, 1995·Nature Medicine·S M BlowerA R Moss
Jun 1, 1995·International Journal of Epidemiology·M R van Cleeff, H J Chum
Dec 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M C RaviglioneA Kochi
Dec 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J P CegielskiF Sheriff
Jun 26, 1995·Archives of Internal Medicine·D R BurwenI M Onorato
Apr 1, 1995·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·L X ZhangX X Liu
Jul 27, 1995·The New England Journal of Medicine·T R FriedenM A Hamburg
Jan 18, 1995·JAMA : the Journal of the American Medical Association·M C RaviglioneA Kochi
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·B E JonesP F Barnes
Aug 17, 1994·JAMA : the Journal of the American Medical Association·M F CantwellI M Onorato
Aug 1, 1993·Annals of Internal Medicine·S MorenoD López-Gay
Nov 1, 1993·The Medical Clinics of North America·J H Bates, W W Stead
Jun 1, 1993·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M DattaR Prabhakar
Jun 1, 1993·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A M ElliottK P McAdam
Feb 25, 1993·The New England Journal of Medicine·M GobleC R Horsburgh
Apr 1, 1993·The American Review of Respiratory Disease·R J BrindleP Waiyaki
Jul 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·W C MillerG J Lallinger
Jul 1, 1996·American Journal of Respiratory and Critical Care Medicine·C L DaleyJ F Murray
Jun 1, 1996·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·F DrobniewskiC Besse
Aug 1, 1996·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·F DrobniewskiC Besse
Aug 1, 1996·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·P SudreJ D Lundgren
Jul 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T A Duong
Oct 1, 1996·American Journal of Respiratory and Critical Care Medicine·R E ChaissonN A Halsey
Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L CohnM C Raviglione

❮ Previous
Next ❯

Citations

May 18, 2005·Social Science & Medicine·Jim Yong KimPaul Farmer
Sep 19, 2003·International Journal of Antimicrobial Agents·Miguel ViveirosLeonard Amaral
Sep 9, 2004·The Journal of Experimental Medicine·Petros C KarakousisWilliam R Bishai
Jun 13, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Deepak AlmeidaAjita Mehta
Dec 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jerod N ScholtenPaula I Fujiwara
Sep 1, 2005·Surgical Infections·Mario W KatigbakSharon Calaman
Nov 13, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Qing-Feng SunGuo-Zhi Wang
Aug 22, 2008·AJR. American Journal of Roentgenology·Yeon Joo Jeong, Kyung Soo Lee
Apr 29, 2008·Emerging Infectious Diseases·Sonya S ShinPeter Cegielski
Aug 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·John L DahlClifton E Barry
Jan 18, 2006·The Journal of Hospital Infection·H AkanO A Akan
May 27, 2008·Dental Clinics of North America·Mark V ThomasRobert Q Frazer
May 7, 2013·European Journal of Medicinal Chemistry·Ahmed KamalBagul Chandrakant
Dec 17, 2011·Microbiology·Arshad Khan, Dhiman Sarkar
Apr 5, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Majid M Heravi, Mansoureh Daraie
May 20, 2015·Developing World Bioethics·Nathan Geffen
Mar 5, 2003·Expert Opinion on Pharmacotherapy·Damian Walker, Warren Stevens
Mar 9, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Ki-Eun HwangHak-Ryul Kim
Jan 8, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Georgios PappasMatthew E Falagas
Sep 16, 2006·Tuberculosis·Robert L ElwoodMichele Trucksis
Mar 12, 2016·International Journal of Mycobacteriology·Dmytro O ButovTatyana S Butova
Aug 6, 2020·Journal of Clinical Imaging Science·Ahmad Umar KhanShreshtha Jain
Feb 6, 2014·Organic & Biomolecular Chemistry·Shailesh P SatasiaDipak K Raval
Mar 8, 2017·Chemical Biology & Drug Design·Yasodakrishna SajjaJagadeesh Babu Nanubolu
Oct 27, 2005·Tuberculosis·U D Gupta, V M Katoch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Kirk M Chan-Tack, Eli N Perencevich
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Pi ChengYi-Zeng Liang
BMC Medical Informatics and Decision Making
Athanasios TsalatsanisBenjamin Djulbegovic
Clinical Evidence
Paul Garner, Alison Holmes
© 2022 Meta ULC. All rights reserved